Prostate cancer involving the bladder neck: Recurrence-free survival and implications for AJCC staging modification

被引:36
作者
Dash, A
Sanda, MG
Yu, MG
Taylor, JMG
Fecko, A
Rubin, MA
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Urol Sect, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/S0090-4295(02)01727-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. In the American Joint Committee on Cancer (AJCC) TNM staging system, prostate cancer involving the bladder neck after radical prostatectomy is considered pT4 disease, suggesting a high risk of recurrence. The recurrence risk with pathologic invasion of the bladder neck, however, has not been definitively compared with that associated with extra-organ disease. We therefore compared the recurrence risk in cases with bladder neck involvement with that of cases with extraprostatic extension and/or seminal vesicle invasion. Methods. The study cohort was composed of 1123 men with clinically localized prostate cancer treated with prostatectomy as monotherapy. The preoperative prostate-specific antigen (PSA) level, bladder neck involvement, margin positivity, Gleason score, and other pathologic categories were assessed as covariates contributing to the PSA-recurrence risk in univariate and multivariable models. Results. Bladder neck involvement was found in 60 (5%) of 1123 cases. In univariate analysis, the bladder neck was the site-specific margin with the greatest PSA-recurrence risk of focal involvement (relative risk 1.52, 95% confidence interval [CI] 1.15 to 2.00, P = 0.0030). The PSA-recurrence relative risk with extraprostatic extension was 3.05 (95% CI 2.13 to 4.38, P < 0.0001) and with seminal vesicle invasion was 8.59 (95% CI 5.76 to 12.82, P < 0.0001). In the multivariable model, the PSA-recurrence risk with bladder neck involvement (relative risk 1.19, 95% CI 0.72 to 1.96, P = 0.5) was not a significant independent prognostic factor. Extraprostatic extension (relative risk 2.25, 95% CI 1.54 to 3.27, P < 0.0001) and seminal vesicle invasion (relative risk 4.12, 95% CI 2.57 to 6.62, P < 0.0001) were significant independent predictors of PSA recurrence. Conclusions. Any staging system should be evidence based. The current AJCC system for staging bladder neck involvement, however, is contrary to the available evidence. Reclassification of bladder neck involvement as part of the pT3 category should be considered. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 15 条
[1]   Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy [J].
Blute, ML ;
Bostwick, DG ;
Bergstralh, EJ ;
Slezak, JM ;
Martin, SK ;
Amling, CL ;
Zincke, H .
UROLOGY, 1997, 50 (05) :733-739
[2]   A MULTIVARIATE-ANALYSIS OF CLINICAL AND PATHOLOGICAL FACTORS THAT PREDICT FOR PROSTATE-SPECIFIC ANTIGEN FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER [J].
DAMICO, AV ;
WHITTINGTON, R ;
MALKOWICZ, SB ;
SCHULTZ, D ;
SCHNALL, M ;
TOMASZEWSKI, JE ;
WEIN, A .
JOURNAL OF UROLOGY, 1995, 154 (01) :131-138
[3]   Disease progression following radical prostatectomy in men with Gleason score 7 tumor [J].
Epstein, JI ;
Pound, CR ;
Partin, AW ;
Walsh, PC .
JOURNAL OF UROLOGY, 1998, 160 (01) :97-100
[4]   Prediction of progression following radical prostatectomy - A multivariate analysis of 721 men with long-term follow-up [J].
Epstein, JI ;
Partin, AW ;
Sauvageot, J ;
Walsh, PC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (03) :286-292
[5]  
Fleming ID, 1997, AJCC CANC STAGING MA, P219
[6]  
Grignon DJ, 1996, CANCER-AM CANCER SOC, V78, P337, DOI 10.1002/(SICI)1097-0142(19960715)78:2<337::AID-CNCR23>3.0.CO
[7]  
2-W
[8]  
Montie JE, 1996, CANCER, V78, P341, DOI 10.1002/(SICI)1097-0142(19960715)78:2<341::AID-CNCR24>3.0.CO
[9]  
2-V
[10]   Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases [J].
Moul, JW ;
Connelly, RR ;
Lubeck, DP ;
Bauer, JJ ;
Sun, L ;
Flanders, SC ;
Grossfeld, GD ;
Carroll, PR .
JOURNAL OF UROLOGY, 2001, 166 (04) :1322-1327